The NIOSH Pocket Guide describes 3,3'-dichlorobenzidine and its salts as a gray-to-purple crystalline solid and identifies inhalation, skin absorption, ingestion, skin, and eye contact routes; reported effects include sensitization, dermatitis, neurologic and urinary symptoms, gastrointestinal upset, upper respiratory infection, a potential occupational carcinogen notation, and animal liver and bladder cancer.
Source: html ↗ · saved source
Exposure Limits; Physical Description; Exposure Routes; Symptoms; Target Organs; Cancer Site · 1
Exposure Limits; Physical Description; Exposure Routes; Symptoms; Target Organs; Cancer Site · 1
Physical Description Gray to purple, crystalline solid. Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact. Symptoms Skin sensitization, dermatitis; headache, dizziness; caustic burns; frequent urination, dysuria; hematuria (blood in the urine); gastrointestinal upset; upper resp infection; [potential occupational carcinogen]. Target Organs Bladder, liver, lung, skin, gastrointestinal tract. Cancer Site [in animals: liver & bladder cancer].